Cargando…

Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status

BACKGROUND: Poor initial response to tamoxifen due to CYP2D6 polymorphism and adverse side effects are two clinical challenges in tamoxifen therapy. We report the development and preclinical testing of a boronic prodrug to orally deliver 4-OHT at therapeutically effective concentrations but at a fra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Qiu, Zhang, Changde, Zhang, Qiang, Miele, Lucio, Zheng, Shilong, Wang, Guangdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563833/ https://www.ncbi.nlm.nih.gov/pubmed/26354796 http://dx.doi.org/10.1186/s12885-015-1621-2

Ejemplares similares

Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
por: Zhang, Changde, et al.
Publicado: (2019)

On the Mechanism of Membrane Permeabilization by Tamoxifen and 4-Hydroxytamoxifen
por: Ortiz, Julia, et al.
Publicado: (2023)

Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)
por: Zhang, Changde, et al.
Publicado: (2017)

Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants
por: Sun, Dongxiao, et al.
Publicado: (2006)

Transporting Antitumor Drug Tamoxifen and Its Metabolites, 4-Hydroxytamoxifen and Endoxifen by Chitosan Nanoparticles
por: Agudelo, Daniel, et al.
Publicado: (2013)

No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats
por: Raju, Kanumuri Siva Rama, et al.
Publicado: (2015)

Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies
por: Liu, Jiawang, et al.
Publicado: (2021)

Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling
por: Asp, Michelle L., et al.
Publicado: (2013)

Development and validation of UPLC-MS/MS method for studying the pharmacokinetic interaction of dasabuvir and tamoxifen, 4-hydroxytamoxifen in Wistar rats
por: Almomen, Aliyah, et al.
Publicado: (2020)

Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen
por: Jager, N. G. L., et al.
Publicado: (2012)

Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing
por: Zhao, Zhenghao, et al.
Publicado: (2023)

An Orally Bioavailable (Mice) Prodrug of Glutathione
por: Crankshaw, Daune L., et al.
Publicado: (2021)

Genetic dissection of clonal lineage relationships with hydroxytamoxifen liposomes
por: Ransom, Ryan C., et al.
Publicado: (2018)

Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells
por: Calhoun, Sarah, et al.
Publicado: (2022)

Boron: More Than an Essential Element for Land Plants?
por: Pereira, Greice Leal, et al.
Publicado: (2021)

Author Correction: Genetic dissection of clonal lineage relationships with hydroxytamoxifen liposomes
por: Ransom, Ryan C., et al.
Publicado: (2018)

Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents
por: Zheng, Shilong, et al.
Publicado: (2014)

CYP2D6 genotype and tamoxifen response
por: Rae, James M, et al.
Publicado: (2005)

GSK5182, 4-Hydroxytamoxifen Analog, a New Potential Therapeutic Drug for Osteoarthritis
por: Min, Yunhui, et al.
Publicado: (2020)

Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome
por: Zhang, Huiyun, et al.
Publicado: (2022)

ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models
por: Guo, Shanchun, et al.
Publicado: (2018)

Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen
por: Wang, Hongyue, et al.
Publicado: (2021)

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
por: Ferraldeschi, Roberta, et al.
Publicado: (2010)

Orally Bioavailable Prodrugs of ψ-GSH: A Potential Treatment for Alzheimer’s Disease
por: Xie, Wei, et al.
Publicado: (2022)

Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
por: Lee, Clara Inkyung, et al.
Publicado: (2020)

Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review
por: Qandil, Amjad M.
Publicado: (2012)

Tocopherol more bioavailable than tocopheryl-acetate as a source of vitamin E for broilers
por: van Kempen, Theo A. T. G., et al.
Publicado: (2022)

Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer
por: Maximov, Philipp Y., et al.
Publicado: (2018)

4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice
por: Heinen, Andre, et al.
Publicado: (2021)

Synthesis and SAR Analysis of Novel 4-Hydroxytamoxifen Analogues Based on Their Cytotoxic Activity and Electron-Donor Character
por: Duró, Cintia, et al.
Publicado: (2022)

The ethics of CYP2D6 testing for patients considering tamoxifen
por: Hartman, Anne-Renee, et al.
Publicado: (2007)

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset
por: Damkier, Per, et al.
Publicado: (2017)

Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats
por: Chae, Kyung-Ae, et al.
Publicado: (2007)

Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport
por: Quach, Tim, et al.
Publicado: (2022)

Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis
por: Krüger-Genge, Anne, et al.
Publicado: (2023)

Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
por: Sanchez Spitman, A. B., et al.
Publicado: (2017)

Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling
por: Hicks, Chindo, et al.
Publicado: (2012)

Comparison of cytotoxicity and genotoxicity of 4-hydroxytamoxifen in combination with Tualang honey in MCF-7 and MCF-10A cells
por: Yaacob, Nik Soriani, et al.
Publicado: (2014)

Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants
por: Pawlik, Anna, et al.
Publicado: (2015)

Lipidome and metabolome analyses reveal metabolic alterations associated with MCF-7 apoptosis upon 4-hydroxytamoxifen treatment
por: Nishimoto, Kazuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jdrri8tcd4hint5act100f86ca